Recruiting
Safety and Efficacy of CD19-BCMA Targeted CAR-T Therapy for Refractory Generalized Myasthenia Gravis
NCT06371040
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +10 more
- Locations
-
- Tangdu Hospital, The Fourth Military Medical University Xi'an, Shaanxi, China